COGT News and Press, Cogent Biosciences Inc Com From 05/12/21

Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results IND cleared for Phase 2 study of CGT9486, a selective mutant KIT inhibitor, in Advanced Systemic Mastocytosis patients John Robinson, PhD appointed as Chief Scientific Officer to l...

Cogent Biosciences ([[COGT]] +0.8%) appointed 15-years industry veteran Evan Kearns as Chief Legal Officer to oversee all corporate legal operations for the company.Most recently, he served as VP, General Counsel, Corporate Secretary and Chief Compliance Officer at Agenus....

Cogent Biosciences Appoints Evan Kearns as Chief Legal Officer PR Newswire CAMBRIDGE , Mass. and BOULDER, Colo. , May 3, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision thera...

Cogent Biosciences Announces Creation of Cogent Research Team Names industry veteran John Robinson, PhD as Chief Scientific Officer New Boulder-based team with exceptional track record of drug discovery and development focused on creating novel small molecule therapies for r...

Cogent Biosciences to Present at LifeSci Partners Virtual Precision Oncology Day 2021 PR Newswire CAMBRIDGE, Mass. , Feb. 11, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for ...

Click here to read the previous top NASDAQ biotech stocks article. It’s been a stellar year for the NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ), which started at 3,763.05 points in January and reached a high of 4,811.03 points on December 15. While the inde...

Cogent Biosciences (COGT) is up +3.8% after Piper Sandler initiated the coverage with an overweight rating on the stock. The price target at $22 per share is +80.3% to yesterday’s close.Noting that the ‘risk/reward now meaningfully skews to the upside after the company...

Gainers: MingZhu Logistics (YGMZ) +237%.Nxt-ID (NXTD) +99%.PainReform (PRFX) +39%.Takung Art (TKAT) +39%.Avenue Therapeutics (ATXI) +31%.Eloxx Pharmaceuticals (ELOX) +30%.Jupiter Wellness (JUPW) +29%.Vivos Therapeutics (VVOS) +25%.Cogent Biosciences (COGT) +24%.Marathon Patent ...

Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares CAMBRIDGE, Mass. , Dec. 4, 2020 /PRNewswire/ -- Cogent Biosciences, Inc. ("Cogent") (NASDAQ: COGT), a biotechnolog...

Cogent Biosciences (COGT) has priced 10,256,411 common shares at $9.75/share, for gross proceeds of ~$100M (from $60M).Underwriters over-allotment is an additional 1,538,461 shares.Offering is expected to close on December 4. Net proceeds will be used for development, regulatory and commercia...